Glenmark Pharmaceuticals Inc., USA

Glenmark Pharmaceuticals Inc., USA: 4 recalls listed since June 2026 across FDA.

By year

Abiraterone Acetate Tablets have a labeling issue.

Moderate riskFDAOct 23, 2026Labeling error

Clindamycin Phosphate Foam, 1% may leak from a defective container.

Moderate riskFDAOct 1, 2026Packaging defect

Azelaic Acid Gel, 15%, 50 gram tubes may have abnormal texture or consistency described as grainy, gritty, or sandy.

Moderate riskFDAJul 28, 2026Manufacturing problem

Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.

Moderate riskFDAJun 12, 2026Drug impurity